UnoReady^® delivers the safety and efficacy of COSENTYX 300 mg/2 mL in a single injection^3*

Adult patients prescribed a COSENTYX dosage of 300 mg can get started with the UnoReady^® pen^{3 ‡}

Remove the UnoReady^® pen from the refrigerator 30 to 45 minutes before injection to allow it to reach room temperature.³

*Per loading and maintenance dose for patients prescribed 300 mg.
^†Please note that while the UnoReady^® pen's cap is not made with natural rubber latex, it is made in the same factory as the Sensoready^® pen's cap that does contain latex.^3
‡The 150-mg Sensoready^® pen is still available, so patients can continue therapy without disruption.

The UnoReady^® pen decreases the injection burden some patients may feel when prescribed a biologic by increasing injection convenience

In a study of adult patients with moderate to severe PsO

Watch a step-by-step guide on how to use the UnoReady^® pen

Please note that if existing patients want to use the UnoReady^® pen, they may need a prior authorization (PA).

Positive injection experience with the Sensoready^® pen^1§

Each pen contains 150 mg/mL of COSENTYX

• Each 300 mg/2 mL dose is supplied in a carton containing two 150-mg/mL Sensoready^®  pens

• Each 150 mg/1 mL dose is supplied in a carton containing one 150-mg/1 mL Sensoready^® pen

Prefilled syringes are also available—each contains 150 mg/1 mL or 75 mg/mL³

^§Co-primary end points of the JUNCTURE study were efficacy of COSENTYX vs placebo at Week 12 based on PASI 75 responses and scores of 0 or 1 and a ≥2-grade improvement from baseline on the IGA mod 2011 scale. Secondary end points included usability of the autoinjector, determined by observer rating of successful, hazard-free self-injection, and subject rating of autoinjector acceptability.⁴

The Sensoready^® pen can be operated without assistance^4#

See the prefilled syringe injection video